ProRx Pharma recently launched its new Liquid Nanoemulsion Delivery System, which is designed to improve patient convenience with a needle-free option to traditional injectable medications. In this system, particles are encapsulated in a lipid-based format, allowing them to be absorbed directly into the bloodstream through the tissues in the mouth—under the tongue or inside the cheek—bypassing the stomach and digestive system. “Healthcare providers are increasingly seeking fast-acting therapies that deliver both reliability and convenience,” says Kurt Lunkwitz, chief operating officer at ProRx. “Our new Liquid Nanoemulsion Delivery System allows ProRx to offer customized formulations from the Bulk Drug Substances list for providers who are looking to minimize injections for their patients without compromising results. Our investment in this technology underscores our commitment to safety, science, and innovation—giving clinicians a new option for patients who choose or need non-injectable therapies.”
This faster absorption may help the body start using these oral therapies sooner, potentially leading to desired results and patient outcomes quicker. The new ProRx delivery system gives providers one more tool in the arsenal of preventative health and personalized medicine offerings for patients seeking wellness solutions.